🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Six ESC and six EACTS appointees reviewed the evidence for stable patients with left main disease, low or intermediate SYNTAX score, low predicted surgical risk, and suitable anatomy for PCI and CABG. The result was a revised class IIa for PCI. academic.oup.com/eurheartj/adva…

Very proud of this publication. Thanks to Lene Nyhus Andreasen Omeed Neghabat Evald Høj Christiansen Dr Peter O'Kane jcspratt Simone Biscaglia FRANCESCO BURZOTTA Jacob Odenstedt Thue Olsen Department of Cardiology Research AUH Aarhus Uni.hospital Aarhus Universitet

Five-year major cardiovascular events are increased when coronary revascularization is guided by iFR compared to FFR: a pooled analysis of iFR-SWEDEHEART and DEFINE-FLAIR trials. academic.oup.com/eurheartj/adva… #iFR #FFR #physiology #outcome #ESC2023 European Society of Cardiology European Society of Cardiology Journals

Evidence-based OCT guided PCI in your lab? OCTOBER Trial instructions: ars.els-cdn.com/content/image/… Lene Nyhus Andreasen Omeed Neghabat Evald Høj Christiansen Dr Peter O'Kane jcspratt Dr Koltowski FRANCESCO BURZOTTA Thue Olsen Ashkan Eftekhari James Cockburn Simone Biscaglia

Revision of ESC guidelines for myocard revasc is not imminent. In the meantime the message across multiple meetings the past weeks is clear: IC imaging needs to be used more in complex PCI. It is the evidence. Tom Johnson Lene Nyhus Andreasen Omeed Neghabat Evald Høj Christiansen Dr Peter O'Kane

In patients w/ cardiovascular disease & overweight or obesity but no diabetes, semaglutide was superior to placebo in lowering the risk of major adverse cardiovascular events at a mean follow-up of 39.8 mos. Full SELECT trial results: nej.md/465pj91 #AHA23 AHA Science

Presented at #AHA23: ORBITA-2 trial: In patients with stable angina who were receiving little or no antianginal medication and had documented ischemia, PCI resulted in a better health status with respect to angina than placebo at 12 weeks. Full results: nej.md/3u21tO2

Det andet projekt ser på muligheden for at spare tusindvis af timer på indlæggelser og transport ved at foretage CT-scanninger lokalt og lade læger på højtspecialiserede afdelinger vurdere og diskutere fundene. Hvis resultaterne er gode, vil det være en enorm gevinst for alle.

Presented at #ACC24: Hospitalized patients with acute myocardial infarction & preserved EF were assigned to receive open-label long-term beta-blocker therapy or not. Beta-blockers did not lead to a lower risk of death or MI. Full REDUCE-AMI trial results: nej.md/4akVhRx

🚨🚨

Why imaging during PCI improves outcomes: rare but dangerous stent mishaps are corrected. Very important OCTOBER substudy. Well done Lene Nyhus Andreasen Niels R. Holm Evald Høj Christiansen OCTOBER Trial

I strongly recommend this course by CoreAalst for anybody interested in CT guided PCI. (That should be all interventional cardiologists.)

🚨#FLOW: The most anticipated trial of the year now published in NEJM with #ERA24 Semaglutide 1.0mg once weekly disease modifying with kidney, CV, & mortality benefits in people w T2D+CKD, cementing itself as a new pillar of care. 🧵 on key thoughts 👇🏾 nejm.org/doi/full/10.10…

"Coronary stent edge segments as determinant of clinical outcomes. An @octobertrial substudy" - is presented today at 15:00 by Søren-Haldur Bülow Rasmussen in Science Box 2 - Research Gateway #ESCcongress2024 Evald Høj Christiansen Lene Nyhus Andreasen Omeed Neghabat @kennethspure Thue Olsen #cardiotwitter #octfirst